Precision BioSciences (FRA:PBS0) Total Stockholders Equity : €34.23 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences Total Stockholders Equity?

Precision BioSciences's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €34.23 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Precision BioSciences's Book Value per Share for the quarter that ended in Mar. 2024 was €4.95. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Precision BioSciences's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.83.

Precision BioSciences Total Stockholders Equity Historical Data

The historical data trend for Precision BioSciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences Total Stockholders Equity Chart

Precision BioSciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

124.48

36.52

80.68

57.05

17.30

Precision BioSciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															37.53	31.42	27.23	17.30	34.23

Precision BioSciences (FRA:PBS0) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Precision BioSciences's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(34.23	-	0)	/	6.91624
	=	4.95

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Precision BioSciences's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(21.751	+	6.818)	/	34.23
	=	0.83

Precision BioSciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Precision BioSciences (FRA:PBS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

DTIL:USA

Address

302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701

Website

https://www.precisionbiosciences.com

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines